ASCO सार्वजनिक
[search 0]
अधिक
Download the App!
show episodes
 
Artwork

1
ASCO Guidelines

American Society of Clinical Oncology (ASCO)

Unsubscribe
Unsubscribe
मासिक+
 
ASCO Guidelines features key recommendations from the latest evidence-based clinical practice guidance from ASCO that you can access on the go.
  continue reading
 
Artwork

1
ASCO Education

American Society of Clinical Oncology (ASCO)

Unsubscribe
Unsubscribe
मासिक
 
The ASCO Education Podcast features expert conversations on the most talked-about topics in oncology today from physician burnout, medical cannabis, COVID and cancer and more…
  continue reading
 
Artwork

1
imparare ascoltando

Simone Roldo

Unsubscribe
Unsubscribe
मासिक
 
in questo podcast potrete ascoltare delle lezioni di matematica e in futuro anche di altri argomenti ogni stagione sta a significare un ambito: stagione 1 = matematica Stagione 2 = storia dell'arte
  continue reading
 
Artwork

1
ASCO in Action Podcast

American Society of Clinical Oncology (ASCO)

Unsubscribe
Unsubscribe
मासिक
 
The ASCO in Action Podcast provides analysis and commentary on cancer policy and practice issues. The podcast is hosted by Dr. Clifford Hudis, CEO of the American Society of Clinical Oncology. ASCO in Action, the society’s internal wire-service, provides the latest news and analysis related to cancer policy. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community. ...
  continue reading
 
Royal Ascot – A New Era in Style, is hosted by fashion industry commentator Scott Wimsett and features personalities from the world of fashion, food and millinery, including Bay Garnett, Arizona Muse, Simon Rogan and Stephen Jones OBE.Brought to you by Ascot Racecourse, home of Royal Ascot, this Podcast series celebrates fashion and food trends ahead of 2021's event - set to take place from 15th - 19th June.Find out more: http://ascot.co.uk/ Hosted on Acast. See acast.com/privacy for more in ...
  continue reading
 
Benvenuti a doppiospresso, l'italiano in corso! Con noi trovate contenuti dedicati alla letteratura italiana, per migliorare ascolto e comprensione in italiano... Impariamo sempre cose nuove sulla cultura italiana, perché... chi ama, ascolta! Welcome to doppioespresso, l'italiano in corso! Here you'll find contents of Italian literature and you'll improve your listening comprehension in Italian. Learn more about Italian language and culture, stay curious, follow us!
  continue reading
 
Tutte le novità sul mondo dei motori, raccontate in maniera competente da piloti e giornalisti del settore. In ogni puntata approfondimenti per tutti gli appassionati di auto, moto e bici. Commentiamo per te le nostre prove, le classifiche, le comparative e le notizie più importanti di red-live.it. RED Live è una creatura di Stefano Cordara, Marco Selvetti ed Edoardo Margiotta: Stefano il giornalista di moto più esperto in Italia, Marco ex Pit Reporter della MotoGP. Edoardo esperto giornalis ...
  continue reading
 
Artwork

1
Buon ascolto

Giada Centofanti

Unsubscribe
Unsubscribe
मासिक
 
Come costruire un business solido e gratificante? E come evitare che il lavoro risucchi anche il nostro tempo libero? Giada Centofanti e Alessia Lobascio non hanno la risposta in tasca ma sono pronte a indagare: si faranno aiutare dalle vostre storie e da forti dosi di ca**eggio e humour, che non guastano mai. Ci sarà anche l’aiuto delle stelle, ma questo è uno spoiler. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Questo è “Recensioni Podcast” by ascoltarepodcast, lo show di Content Curation dedicato a chi ama divertirsi, informarsi e, perché no, anche formarsi tramite questo bellissimo media digitale che è il podcast. Ci trovi su: recensionipodcast.pagineinrete.net/ Su Telegram, dal lunedì al venerdì, (https://t.me/recensionipodcast) trovi recensioni, notizie, chiacchiere sui podcast e quel che ci gira intorno. Ti aspettiamo. Stefano e Antonino.
  continue reading
 
Loading …
show series
 
Dr. John Sweetenham shares highlights from Day 3 of the 2024 ASCO Annual Meeting, including selected studies on the treatment of cancer cachexia, surgical approaches in advanced ovarian cancer, and advanced colorectal cancer with liver metastases. TRANSCRIPT Dr. John Sweetenham: I'm Dr. John Sweetenham, the host of the ASCO Daily News Podcast, with…
  continue reading
 
Dr. Jyoti Patel discusses the latest update to the stage IV NSCLC with driver alterations living guideline, specifically for patients with EGFR or ROS1 alterations. She shares the latest recommendations based on recently published evidence, such as the FLAURA2, MARIPOSA-2, and TRIDENT-1 trials. Dr. Patel talks about how to choose between these new …
  continue reading
 
Dr. John Sweetenham shares highlights from Day 2 of the 2024 ASCO Annual Meeting, including potentially practice-changing results in advanced Hodgkin lymphoma, intriguing data on the effect of metformin on active surveillance for prostate cancer, and the potential of AI to improve patient outreach and adherence to medical appointments. TRANSCRIPT D…
  continue reading
 
In the first episode of a special daily series during the 2024 ASCO Annual Meeting, Dr. John Sweetenham shares highlights from Day 1, including exciting data on the CROWN trial in NSCLC, the ASC4First study in chronic myeloid leukemia, and the effects of high-deductible health plans on cancer survivorship. TRANSCRIPT Dr. John Sweetenham: I'm Dr. Jo…
  continue reading
 
Dr. Shaalan Beg and Dr.Mohamed Salem discuss key abstracts that will be presented at the 2024 ASCO Annual Meeting, including hypoxia-response CAR T- cell therapy for solid tumors, GPC3-specific CAR T- cell therapy in hepatocellular carcinoma, and the promising efficacy of targeted therapies in GI cancers. TRANSCRIPT Dr. Shaalan Beg: Hello and welco…
  continue reading
 
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting. TRANSCRIPT Dr. Neeraj Agarwal: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Neeraj Agarwal, your guest host of the ASCO Daily News Podcast today. I'm t…
  continue reading
 
Dr. Diwakar Davar and Dr. Jason Luke discuss key abstracts from the 2024 ASCO Annual Meeting that explore triplet therapy in advanced melanoma, TIL cell therapy in immune checkpoint inhibitor–naive patients, and other novel approaches that could shape the future of immunotherapy in melanoma and beyond. TRANSCRIPT Dr. Diwakar Davar: Hello and welcom…
  continue reading
 
Dr. John Sweetenham and Dr. Marc Braunstein look ahead at key abstracts across the spectrum of hematologic malignancies that will be presented at the 2024 ASCO Annual Meeting, including the OPTIC trial in chronic myeloid leukemia, treatment options for transplant-ineligible patients with multiple myeloma, and the 7-year analysis of the ECHELON-1 tr…
  continue reading
 
Dr. Allison Zibelli and Dr. Megan Kruse discuss the potential benefit of endocrine therapy in ER-low breast cancer; the efficacy and tolerability of triplet therapy in PIK3CA-mutated, HER2-negative locally advanced or metastatic breast cancer; and more key research that will be featured at the 2024 ASCO Annual Meeting. TRANSCRIPT Dr. Allison Zibell…
  continue reading
 
Drs. Vamsi Velcheti and Nathan Pennell discuss key lung cancer abstracts from the 2024 ASCO Annual Meeting, including data from LUMINOSITY and ADAURA, novel therapies in KRASG12C-mutant advanced NSCLC, and the need for effective adjuvant therapies for patients with rare mutations. TRANSCRIPT Dr. Vamsi Velcheti: Hello, I am Dr. Vamsi Velcheti, your …
  continue reading
 
Dr. Bradley Hunter, MD, MPH and Ms. Amy Evers, BSN, RN, OCN, MBA join us on the latest episode of the ASCO Guidelines Podcast to share key points and insights on the updated ASCO-ONS antineoplastic therapy administration safety standards for adult and pediatric oncology standards. They highlight key updates across the four standards domains: (1) cr…
  continue reading
 
Dr. Rachel Freedman and Dr. Sharon Giordano share the latest rapid guideline update from ASCO on the adjuvant use of the CDK4/6 inhibitors abemaciclib and ribociclib in patients with stage II and III breast cancer. They share details on the impetus for the update, supporting evidence, and considerations of benefits and harms for individuals. Additi…
  continue reading
 
Dr. Karen Mustian joins us to share the latest update to the management of fatigue in adult survivors of cancer guideline from the American Society of Clinical Oncology and the Society for Integrative Oncology. Dr. Mustian highlights the recommendations across the continuum of care, including recommendations for patients with cancer-related fatigue…
  continue reading
 
Dr. Debra Lundquist, PhD, RN and Dr. Arun Ghoshal, MD, MBBS discuss the new update to the palliative care for patients with cancer guideline developed by an interdisciplinary Expert Panel. They share the key updated recommendations on the most effective palliative care interventions, how these recommendations relate to other supportive care service…
  continue reading
 
Dr. Douglas Peterson presents the latest evidence-based guideline from ISOO, MASCC, and ASCO on the prevention and management of osteoradionecrosis (ORN) in patients with head and neck cancer treated with radiation therapy. He covers topics such as recommended initial workup, best practices for prevention of ORN of the head and neck before and afte…
  continue reading
 
Dr. Raymond Chan and Dr. Larissa Nekhlyudov share the newest standards and practice recommendations from MASCC and ASCO on survivorship care for people with advanced or metastatic cancer. They discuss highlights of the standards across seven domains: person-centered care, coordinated and integrated care, evidence-based and comprehensive care, evalu…
  continue reading
 
Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of neoadjuvant and adjuvant treatment options for patients and the role of surgery in the era of targeted therapy and immuno-oncology in lung cancer. TRANSCRIPT Dr. Vamsi Vel…
  continue reading
 
Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoint inhibitors, or ICIs, in cervical and endometrial cancers. They also examine emerging data that support the use of ICIs in recurrent cervical cancer, the potential for curing some patients with advanced en…
  continue reading
 
Drs. Shaalan Beg and Aparna Parikh discuss the role of ctDNA as a powerful prognostic biomarker for GI cancers, along with its impact on risk stratification and the detection of recurrence. They highlight key studies in ctDNA that were featured at the 2024 ASCO GI Cancers Symposium, including COBRA, GALAXY, and BESPOKE in CRC, as well as the promis…
  continue reading
 
Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be used to provide a personalized risk-benefit profile, inform …
  continue reading
 
Dr. John Gordan discusses the newest evidence-based guideline update from ASCO on systemic therapy for advanced hepatocellular carcinoma (HCC). He shares the updated recommendations for first-, second-, and third-line therapy for patients with Child-Pugh Class A liver disease, guidance for patients with Child-Pugh Class B liver disease. Dr. Gordan …
  continue reading
 
Dr. Lisa Law and Dr. Randy Taplitz share the latest evidence-based recommendations from ASCO on vaccines in adults with cancer. They discuss recommended routine preventative vaccinations, additional vaccinations and revaccinations for adults undergoing HSCT, CD19 CAR-T treatment, or B cell-depleting therapy, guidance for adults with cancer travelin…
  continue reading
 
Ci sono moto che passano e vanno, altre che restano impresse nella memoria di chi le ha possedute. Altre ancora che fanno la storia e diventano leggenda. Moto che vanno oltre il semplice essere moto, ma figlie dei colpi di genio di ingegneri e designer. Dopo il loro arrivo, il mondo non è più lo stesso. In questo episodio di RED Legend parliamo di …
  continue reading
 
Dr. Ilana Braun and Dr. Eric Roeland join us on the ASCO Guidelines podcast to discuss the latest evidence-based recommendations on cannabis and cannabinoids in adults with cancer. They discuss nonjudgmental patient-clinician communication, the relatively narrow cancer-related indications for which there is actionable clinical evidence for cannabis…
  continue reading
 
Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein present the latest breast cancer rapid recommendation update impacting two ASCO guidelines. This update focuses on the new option, capivasertib plus fulvestrant, for patients with hormone receptor-positive, HER2-negative metastatic breast cancer with activating PIK3CA or AKT1 mutations o…
  continue reading
 
Drs. John Sweetenham and Shaji Kumar discuss the emergence of CAR T-cell therapy for multiple myeloma, its benefits and challenges for patients, and its potential role earlier in the treatment of disease. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham from the UT Southwestern Harold C. Simmons Comprehensive Cancer Center and host of…
  continue reading
 
Dr. Natash Leighl and Dr. Jyoti Patel are back on the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. This guideline includes recommendations for first-, second-, and subsequent-line therapy for patients with driver alterations including: EGFR, ALK, ROS1, BRAFV600E, MET exon skipping mutation, RET re…
  continue reading
 
Dr. Jyoti Patel and Dr. Natasha Leighl discuss the latest full update to the stage IV NSCLC without driver alterations living guideline. This guideline addresses first-, second-, and subsequent-line therapy for patients according to their histology (squamous cell and nonsquamous cell carcinomas) and PD-L1 expression. They discuss the streamlined re…
  continue reading
 
Drs. Hope Rugo and Sara Tolaney discuss the promise of antibody-drug conjugates (ADCs) in the treatment of breast cancer, highlighting key trials that shed light on matching the right ADC to the right patient in the right setting. They also explore how combinations and sequencing of ADCs can augment their efficacy, the mechanisms of resistance, and…
  continue reading
 
Drs. Shaalan Beg and Rachna Shroff discuss key abstracts on GI cancers that were featured at the 2024 ASCO Gastrointestinal Cancers Symposium, including SKYSCRAPER-08, EMERALD-1, and NEST-1 in esophageal squamous cell carcinoma, hepatocellular carcinoma, and colorectal cancer, respectively. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO…
  continue reading
 
Drs. Neeraj Agarwal and Todd Morgan discuss CONTACT-02, KEYNOTE-564, CheckMate-67T, and other notable studies featured at the 2024 ASCO Genitourinary Cancers Symposium, as well as additional key abstracts in prostate, kidney, and bladder cancers that will significantly influence clinical practice. TRANSCRIPT Dr. Neeraj Agarwal: Hello, and welcome t…
  continue reading
 
Siamo saliti in sella alla nuova Ducati DesertX Rally, la moto Adventouring più estrema di Ducati. Una prova di due giorni nel deserto del Marocco per capire veramente come va. Ecco le nostre considerazioni post prova in questo nuovo episodio del REDPodcast
  continue reading
 
Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss several key abstracts to be presented at the 2024 ASCO GU Cancers Symposium, including sequencing versus upfront combination therapies for mCRPC in the BRCAAway study, updates on the CheckMate-9ER and CheckMate-214 trials in ccRCC, and a compelling real-world retrospective study in mUC of patients…
  continue reading
 
Dr. Banu Arun and Dr. Sana Al Sukhun share recommendations from the newest ASCO resource-stratified guideline on systemic treatment for patients with metastatic breast cancer. They describe the importance of this new guideline, the four-tier resource setting approach, key recommendations, and implementation considerations. Recommendations are discu…
  continue reading
 
Dr. Isabelle Bedrosian and Dr. Mark Robson discuss the new guideline from ASCO and SSO on germline testing in patients with breast cancer. They discuss the framework for which patients should be offered BRCA1/2 testing, and what additional moderate- and high-penetrance genes may be considered for inclusion in germline testing. They highlight key as…
  continue reading
 
Loading …

त्वरित संदर्भ मार्गदर्शिका